Global Clinical Biomarker Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Cancer
  • 1.3.3 Metabolism
  • 1.3.4 Infectious Disease
  • 1.3.5 Cardiology
  • 1.3.6 Neurology
  • 1.3.7 Immunological Disease
• 1.4 Market by Application
  • 1.4.1 Global Clinical Biomarker Testing Market Share by Application: 2020 VS 2026
  • 1.4.2 Drug Discovery
  • 1.4.3 Nutrigenomics
  • 1.4.4 Toxicology Testing
  • 1.4.5 Personalized Medicine
  • 1.4.6 Functional Genomics
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Clinical Biomarker Testing Market Perspective (2015-2026)
• 2.2 Clinical Biomarker Testing Growth Trends by Regions
  • 2.2.1 Clinical Biomarker Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Clinical Biomarker Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Clinical Biomarker Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Clinical Biomarker Testing Industry Dynamic
  • 2.3.1 Clinical Biomarker Testing Market Trends
  • 2.3.2 Clinical Biomarker Testing Market Drivers
  • 2.3.3 Clinical Biomarker Testing Market Challenges
  • 2.3.4 Clinical Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Clinical Biomarker Testing Players by Market Size
  • 3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
• 3.4 Global Clinical Biomarker Testing Market Concentration Ratio
  • 3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2019
• 3.5 Key Players Clinical Biomarker Testing Area Served
• 3.6 Key Players Clinical Biomarker Testing Product Solution and Service
• 3.7 Date of Enter into Clinical Biomarker Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Biomarker Testing Breakdown Data by Type

• 4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2021-2026)

5 Clinical Biomarker Testing Breakdown Data by Application

• 5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2015-2020)
• 5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Clinical Biomarker Testing Market Size (2015-2026)
• 6.2 North America Clinical Biomarker Testing Market Size by Type (2015-2020)
• 6.3 North America Clinical Biomarker Testing Market Size by Application (2015-2020)
• 6.4 North America Clinical Biomarker Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Clinical Biomarker Testing Market Size (2015-2026)
• 7.2 Europe Clinical Biomarker Testing Market Size by Type (2015-2020)
• 7.3 Europe Clinical Biomarker Testing Market Size by Application (2015-2020)
• 7.4 Europe Clinical Biomarker Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2015-2026)
• 8.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Clinical Biomarker Testing Market Size (2015-2026)
• 9.2 Latin America Clinical Biomarker Testing Market Size by Type (2015-2020)
• 9.3 Latin America Clinical Biomarker Testing Market Size by Application (2015-2020)
• 9.4 Latin America Clinical Biomarker Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2015-2026)
• 10.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
  • 11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2015-2020))
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 AbbVie Inc.
  • 11.2.1 AbbVie Inc. Company Details
  • 11.2.2 AbbVie Inc. Business Overview
  • 11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
  • 11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.2.5 AbbVie Inc. Recent Development
• 11.3 Adaptive Biotechnologies
  • 11.3.1 Adaptive Biotechnologies Company Details
  • 11.3.2 Adaptive Biotechnologies Business Overview
  • 11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
  • 11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.3.5 Adaptive Biotechnologies Recent Development
• 11.4 Agilent Technologies
  • 11.4.1 Agilent Technologies Company Details
  • 11.4.2 Agilent Technologies Business Overview
  • 11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
  • 11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.4.5 Agilent Technologies Recent Development
• 11.5 BD
  • 11.5.1 BD Company Details
  • 11.5.2 BD Business Overview
  • 11.5.3 BD Clinical Biomarker Testing Introduction
  • 11.5.4 BD Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.5.5 BD Recent Development
• 11.6 Becton Dickinson
  • 11.6.1 Becton Dickinson Company Details
  • 11.6.2 Becton Dickinson Business Overview
  • 11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
  • 11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.6.5 Becton Dickinson Recent Development
• 11.7 Bio-Rad Laboratories
  • 11.7.1 Bio-Rad Laboratories Company Details
  • 11.7.2 Bio-Rad Laboratories Business Overview
  • 11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
  • 11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.7.5 Bio-Rad Laboratories Recent Development
• 11.8 Danaher Corporation
  • 11.8.1 Danaher Corporation Company Details
  • 11.8.2 Danaher Corporation Business Overview
  • 11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
  • 11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.8.5 Danaher Corporation Recent Development
• 11.9 Merck and Co.
  • 11.9.1 Merck and Co. Company Details
  • 11.9.2 Merck and Co. Business Overview
  • 11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
  • 11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.9.5 Merck and Co. Recent Development
• 11.10 Thermofisher Scientific
  • 11.10.1 Thermofisher Scientific Company Details
  • 11.10.2 Thermofisher Scientific Business Overview
  • 11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
  • 11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2015-2020)
  • 11.10.5 Thermofisher Scientific Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer